Brandtree

Who owns Allevyn?

Allevyn is owned by Smith+Nephew (the United Kingdom, LSE: SN).[1]

Evidence: Smith & Nephew plc Annual Report on Form 20-F filed 2026-03-16, SEC EDGAR, 16 March 2026. Verified from filings; last checked .

Key facts

Current owner
Smith & Nephew plc verified
Owner HQ
🇬🇧 United Kingdom, Watford
Origin
🇬🇧 United Kingdom
Category
Consumer health › First aid & wound care › Bandages & wound care
Parent ticker
LSE: SN
Last verified
· 1 sources

About Allevyn

Allevyn is Smith+Nephew's range of advanced foam wound dressings within Advanced Wound Management. Its 2025 results announcement names Allevyn Complete Care as a foam dressing and cites its ability to prevent pressure injuries, while the company reports good growth in foam dressings and films within Advanced Wound Care in 2025.

How often Smith+Nephew names Allevyn in its annual report

A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.

Annual report filedTimes Allevyn is named
20263
20253
20242

Ownership timeline of Allevyn

  1. Current owner Smith+Nephew [1] verified

Where Allevyn sits in Smith+Nephew

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Allevyn sits in Smith+Nephew Tree of 3 brands under Smith+Nephew. Smith+Nephew Allevyn Pico Renasys

Open the full Smith+Nephew ownership tree →

See the full Smith+Nephew brand portfolio (3) →

Other brands owned by Smith+Nephew

Smith+Nephew controls 3 brands on Brandtree, 3 of them in consumer health.

Also in consumer health

All Smith+Nephew brands →

Other brands in bandages & wound care, and who owns them

The 20 brands in bandages & wound care on Brandtree belong to 12 owners. The largest is HARTMANN, with 4; Smith+Nephew has 2.

BrandOwnerOwner based in
Atrauman HARTMANN 🇩🇪 Germany
Biatain Coloplast 🇩🇰 Denmark
Aquacel Convatec 🇬🇧 United Kingdom
Nexcare 3M 🇺🇸 United States
Hansaplast Beiersdorf 🇩🇪 Germany
Pantinol Plus Birzeit Pharmaceutical 🇵🇸 Palestine
Makiron Daiichi Sankyo Healthcare 🇯🇵 Japan
JOBST Essity 🇸🇪 Sweden

Every brand in bandages & wound care and its owner →

About the owner: Smith+Nephew

Smith+Nephew is a publicly listed company headquartered in Watford, United Kingdom, founded in 1856. Brandtree records 3 brands under its control, and it is listed as LSE: SN.

Smith+Nephew is a UK-headquartered medical technology company based in Watford that files an annual Form 20-F with the SEC. Its 2025 report describes a 170-year history and revenue of $6,164 million, of which Advanced Wound Management was $1,793 million; the rest is mainly orthopaedics and sports medicine and ENT, which are outside this site's consumer categories.

Smith+Nephew: full profile, brands and acquisition history →

🇬🇧 Allevyn and other British brands

Brandtree records a controlling owner for 543 brands that began in the United Kingdom. 282 of them (52%) are now controlled by a company headquartered in another country; Allevyn is not one of them.

All British brands and who owns them →

Frequently asked questions

Who is the parent company of Allevyn?

The parent company of Allevyn is Smith+Nephew, a publicly listed company headquartered in the United Kingdom.

Is Allevyn British?

Yes. Allevyn originated in the United Kingdom and its owner, Smith+Nephew, is also headquartered in the United Kingdom.

Is Allevyn still owned by Smith+Nephew?

Yes. As of 3 October 2026, Allevyn is still owned by Smith+Nephew. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Smith & Nephew plc Annual Report on Form 20-F filed 2026-03-16 — SEC EDGAR, SEC Form 20-F, published 16 March 2026; retrieved 3 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.